How biotech brands are battling COVID counterfeits

Charlotte Kilpatrick

February 04 2021

Show more sharing options

Anti-counterfeiting sources explain how the biotech industry is responding to a rise in fake COVID medication

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

Charlotte Kilpatrick

Reporter Managing IP

Charlotte reports on patent-related issues. She often covers the European market, focusing on developments including FRAND, licensing and trade secrets. She is particularly interested in how new technologies affect IP challenges in the pharmaceutical industry.

more from across site and SHARED ros bottom lb

More from across our site

Patents

This week on MIP: Paul Weiss faces backlash | Unitary Patent intrigue

A copyright win for AI firm Anthropic and a new executive order against law firm Jenner & Block were also among the top talking points this week

Sukanya Sarkar, March 28 2025

Patents

How AI adoption is shifting one firm’s associate training

A principal at Schwegman Lundberg & Woessner explains how AI tools, including DeepIP, can position the firm to help clients

Rani Mehta, March 27 2025

Patents

How Cleary Gottlieb hopes to differentiate itself with AI acquisition

The firm explains why AI-empowered data analytics could make it a more efficient advocate for its clients

Rani Mehta, March 27 2025

Patents

Weekly take: Why we should train managers in mental health awareness

Penelope Aspinall, of IP wellbeing charity Jonathan’s Voice, explains why managers should take a three-tiered approach to looking after workers’ mental health

Penelope Aspinall, March 27 2025

Patents

China debut ‘long overdue’: Via LA president

Heath Hoglund talks about the value proposition of patent pools and why it went ahead with its first-ever series of pool meetings in China

Sukanya Sarkar, March 27 2025

Patents

The flags of the European Union and the United States of America

Global battlegrounds: an examination of Standard Essential Patents at the UPC v the US ITC

Ryan Richardson, Chris O’Brien, and Jean Selep of Sterne Kessler analyse the treatment of SEPs at the UPC and ITC and highlight why SEP holders and implementers should be mindful of current developments in both forums

Ryan Richardson, March 26 2025

Patents

UPC latest: CJEU’s BSH ruling adopted | Amazon timed out

A ruling concerning the UPC’s jurisdiction, questions over costs transparency, and a missed deadline by Amazon were among the top talking points this fortnight

March 26 2025

What Corporates Want

What Corporates Want: Managing costs a ‘basic expectation’

Exclusive data and analysis reveal how firms can differentiate themselves when it comes to costs and value

Rani Mehta, March 25 2025

Trademarks

Maucher Jenkins lands in Berlin with IP boutique hire

The Berlin office will mark the firm’s fourth German base and tenth overall

Max Walters, March 25 2025

Patents

State of the market: key players in the UK’s IP legal industry

As we build up to another busy year for the IP STARS rankings and Managing IP Awards, we give a rundown of some of the major IP firms and trends in the UK

Sukanya Sarkar, March 25 2025